APLS — курсы расширенных реанимационных мероприятий в педиатрии, спонсируемые Американской академией педиатрии и Американской коллегией врачей неотложной помощи (Advanced Pediatric Life Support)
AVPU — шкала для оценки уровня сознания («в ясном сознании»; «реакция на вербальные раздражители»; «реакция на боль»; «без сознания») (alert, verbal, pain, unresponsive)
CADASIL — церебральная аутосомно-доминантная артериопатия с подкорковыми инфарктами и лейкоэнцефалопатией (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)
DSM — Диагностическое и статистическое руководство по психическим расстройствам (Diagnostic and Statistical Manual of Mental Disorders)
EAST syndrome — эпилепсия, атаксия, сенсоневральная тугоухость и тубулопатия (epilepsy, ataxia, sensorineural hearing loss, and tubulopath)
EBM — доказательная медицина (evidance based medicine)
EPCAM — молекула адгезии эпителиальных клеток (epithelial cell adhesion molecule)
ESC — Европейское общество кардиологии (European Society of Cardiology)
EXIT — лечение плода вне матки во время родов (ех utero intrapartum treatment)
FcRs — Fc-рецепторы — белок, расположенный на поверхности нескольких видов клеток иммунной системы (естественных киллеров, макрофагов, нейтрофилов и тучных клеток) FDA — Комитет по контролю за лекарственными веществами и пищевыми добавками, США (Food and Drug Administration)
MELAS — митохондриальная энцефалопатия, лактоацидоз и инсультоподобные эпизоды (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes)
MELD — модель для оценки терминальной стадии заболеваний печени, предназначена для оценки относительной тяжести заболевания и прогноза жизни у пациентов с терминальной стадией печеночной недостаточности (ожидающих трансплантации печени) (model for end-stage liver disease)
MERRF — миоклоническая эпилепсия с рваными красными волокнами (myoclonic epilepsy with ragged red fibers)
MHC — главный комплекс гистосовместимости (major histocompatibility complex)
Mr — кажущаяся молекулярная масса
MRP — белок с множественной лекарственной устойчивостью (multidrug-resistant protein)
mTOR — мишень рапамицина у млекопитающих (mammalian target of rapamycin)
NB! — важно, обратить внимание (nota bene)
NICE — Национальный институт здоровья и клинического совершенствования (качества медицинской помощи) Великобритании (National Institute for Health and Clinical Excellence)
NK — естественные клетки-киллеры (natural killer) NMDA — И-метил-В-аспартат (N-methyl-D-aspartate)
NNT — число больных, которых необходимо пролечить, чтобы достичь какого-то указанного эффекта (number need to treatment)
OR — отношение шансов (odds ratio)
paCO2 — парциальное давление углекислого газа в артериальной крови
PALS — курсы расширенных реанимационных мероприятий в педиатрии (Pediatric Advanced Life Support)
PANDAS — аутоиммунное нейропсихиатрическое расстройство в детском возрасте, ассоциированное со стрептококковой инфекцией (pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection)
PANS — острый нейропсихиатрический синдром в детском возрасте (pediatric acute-onset neuropsychiatric syndrome)
paO2 — парциальное давление кислорода в артериальной крови
PAS — фуксинсернистая кислота, реактив Шиффа (periodic acid-Shiff)
PC — после еды (при назначениях) (post cibum) рСО2 — парциальное давление углекислого газа
PCSK-9 — пропротеиновая конвертаза субтилизинкексинового типа 9 (proprotein convertase subtilisin/kexin type 9)
PFAPA — периодическая лихорадка с афтозным стоматитом, фарингитом и лимфаденитом (periodic fevers with aphthous stomatitis, pharyngitis and adenitis)
PIM — показатель летального исхода у детей (pediatric index of mortality)
piO2 — парциальное давление кислорода во вдыхаемом воздухе
рО2 — парциальное давление кислорода
POLG — субъединица ДНК-полимеразы γ
PRISA II — оценка риска госпитализации у детей II (pediatric risk of admission)
PRISM — риск летального исхода у детей (pediatric risk of mortality)
PRN — при (по) необходимости (pro re nata — при возникновении обстоятельств)
PRSS — ген сериновой протеазы
PS — примечание (post scriptum)
PUVA-терапия — псорален-ультрафиолет А-терапия (psoralen and ultraviolet А)
Q#H — каждые # часов (при назначениях) (quaque... hora)
QAM — каждое утро (при назначениях) (quaque ante meridiem)
QPM — каждый вечер (при назначениях) (quaque post meridiem)
RAG — ген, активирующий рекомбиназу
RePEAT — пересмотренный инструмент для оценки педиатрической неотложной медицинской помощи (Revised Pediatric Emergency Assessment Tool)
RF — ревматоидный фактор
Rh — резус(-фактор)
Rh«-» — резус-отрицательн(ый)
Rh«+» — резус-положительн(ый)
ROHHAD — быстро развивающееся ожирение с дисфункцией гипоталамуса, гиповентиляцией и спонтанной дисрегуляцией (rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation)
αDG-RD — дистрофии, связанные с α-дистрогликанами (alpha dystroglycan-related dystrophies)
β-ХГЧ — β-субъединица хорионического гонадотропина человека
В ходе подготовки статей по заболеваниям полости рта и ЛОР-органов в терапии для пользователей сайта МедУнивер использованы труды следующих авторов:
Staines K., Greenwood M. Aphthous ulcers (recurrent). BMJ Clin Evid. 2015; 2015:1–30.
Nasry S.A., El Shenawy H.M., Mostafa D. et al. Different modalities for treatment of recurrent aphthous stomatitis. A randomized clinical trial. J Clin Exp Dent. 2016; 8:e517–e522.
Davari P., Hsiao H.H., Fazel N. Mucosal lichen planus: an evidence-based treatment update. Am J Clin Dermatol. 2014; 15:181–195.
Diebold S., Overbeck M. Soft tissue disorders of the mouth. Emerg Med Clin North Am. 2019; 37:55–68.
Edgar N.R., Saleh D., Miller R.A. Recurrent aphthous stomatitis: a review. J Clin Aesthet Dermatol. 2017; 10:26–36.
Taberna M., Mena M., Pavon M.A. et al. Human papillomavirus-related oropharyngeal cancer. Ann Oncol. 2017; 28:2386–2398.
Ikeda K. Drug-induced oral complications. Atlas Oral Maxillofac Surg Clin North Am. 2017; 25: 127–132.
Hellstein J.W., Marek C.L. Candidiasis: red and white manifestations in the oral cavity. Head Neck Pathol. 2019; 13:25–32.
Telles D.R., Karki N., Marshall M.W. Oral fungal infections: diagnosis and management. Dent Clin North Am. 2017; 61:319–349.
Ramanojam S., Merchant Y., Bhardwaj S. et al. Idiopathic sialolithiasis: scalpel versus current trends in management. J Craniofac Surg. 2017; 28:e363–e364.
Carlson E.R., Schlieve T. Salivary gland malignancies. Oral Maxillofac Surg Clin North Am. 2019; 31:125–144.
Wolff A., Joshi R.K., Ekstrom J. et al. A guide to medications inducing salivary gland dysfunction, xerostomia, and subjective sialorrhea: a systematic review sponsored by the World Workshop on Oral Medicine VI. Drugs R D. 2017; 17:1–28.
Robertson D.P., Keys W., Rautemaa-Richardson R. et al. Management of severe acute dental infections. BMJ. 2015; 350:1–8.
Juel-Berg N., Darling P., Bolvig J. et al. Intranasal corticosteroids compared with oral antihistamines in allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2017; 31:19–28.
Kenealy T., Arroll B. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2013; 6:CD000247.
Garbutt J.M., Banister C., Spitznagel E. et al. Amoxicillin for acute rhinosinusitis: a randomized controlled trial. JAMA. 2012; 307:685–692.
Chong L.Y., Head K., Hopkins C. et al. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016; 4:CD011996.
Chong L.Y., Head K., Hopkins C. et al. Saline irrigation for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016; 4:CD011995.
Head K., Chong L.Y., Piromchai P. et al. Systemic and topical antibiotics for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016; 4:CD011994.
Di Bona D., Plaia A., Leto-Barone M.S. et al. Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis: a systematic review and meta-analysis. JAMA Intern Med. 2015; 175:1301–1309.
Virchow J.C., Backer V., Kuna P. et al. Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial. JAMA. 2016; 315: 1715–1725.
Scadding G.W., Calderon M.A., Shamji M.H. et al. Effect of 2 years of treatment with sublingual grass pollen immunotherapy on nasal response to allergen challenge at 3 years among patients with moderate to severe seasonal allergic rhinitis: the GRASS randomized clinical trial. JAMA. 2017; 317:615–625.
Rudmik L., Soler Z.M. Medical therapies for adult chronic sinusitis: a systematic review. JAMA. 2015; 314:926–939.
Head K., Chong L.Y., Hopkins C. et al. Short-course oral steroids as an adjunct therapy for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016; 4:CD011992.
Bachert C., Mannent L., Naclerio R.M. et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial. JAMA. 2016; 315:469–479.
Tapiainen T., Kujala T., Renko M. et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatr. 2014; 168:635–641.
Gluck O., Marom T., Shemesh S. et al. Adult acute rhinosinusitis guidelines worldwide: similarities and disparities. Int Forum Allergy Rhinol. 2018; 8:939–947.
Wyler B., Mallon W.K. Sinusitis update. Emerg Med Clin North Am. 2019; 37:41–54.
Wallace D.V., Dykewicz M.S., Oppenheimer J. et al. Pharmacologic treatment of seasonal allergic rhinitis: synopsis of guidance from the 2017 Joint Task Force on Practice Parameters. Ann Intern Med. 2017; 167:876–881.
Libman H., Brockmeyer D.M., Gold H.S. Should we prescribe antibiotics to this patient with persistent upper respiratory symptoms?: grand rounds discussion from Beth Israel Deaconess Medical Center. Ann Intern Med. 2017; 166:201–208.
Harris A.M., Hicks L.A., Qaseem A. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the CDC. Ann Intern Med. 2016; 164:425–434.
Bequignon E., Verillaud B., Robard L. et al. Guidelines of the French Society of Otorhinolaryngology (SFORL). First-line treatment of epistaxis in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2017; 134:185–189.
Beck R., Sorge M., Schneider A. et al. Current approaches to epistaxis treatment in primary and secondary care. Dtsch Arztebl Int. 2018; 115:12–22.
Heward E., Cullen M., Hobson J. Microbiology and antimicrobial susceptibility of otitis externa: a changing pattern of antimicrobial resistance. J Laryngol Otol. 2018; 132:314–317.
Demir D., Yilmaz M.S., Guven M. et al. Comparison of clinical outcomes of three different packing materials in the treatment of severe acute otitis externa. J Laryngol Otol. 2018; 1–6.
Schilder A.G., Marom T., Bhutta M.F. et al. Panel 7: otitis media: treatment and complications. Otolaryngol Head Neck Surg. 2017; 156:s88–s105.
Schwartz S.R., Magit A.E., Rosenfeld R.M. et al. Clinical practice guideline (update): earwax (cerumen impaction). OtolaryngolHeadNeckSurg. 2017; 156:S1–S29.
Kumbargere Nagraj S., George R.P., Shetty N. et al. Interventions for managing taste disturbances. Cochrane Database Syst Rev. 2017; 12:CD010470.
DeVere R. Disorders of taste and smell. Continuum (Minneap Minn). 2017; 23:421–446.
Roper S.D., Chaudhari N. Taste buds: cells, signals and synapses. Nat Rev Neurosci. 2017; 18:485–497.
Boesveldt S., Postma E.M., Boak D. et al. Anosmia — a clinical review. Chem Senses. 2017; 42:513–523.
Kohli P., Naik A.N., Harruff E.E. et al. The prevalence of olfactory dysfunction in chronic rhinosinusitis. Laryngoscope. 2017; 127:309–320.
Choo E., Dando R. The impact of pregnancy on taste function. Chem Senses. 2017; 42:279–286.
Zhang C., Wang X. Initiation of the age-related decline of odor identification in humans: a metaanalysis. Ageing Res Rev. 2017; 40:45–50.
Hur K., Choi J.S., Zheng M. et al. Association of alterations in smell and taste with depression in older adults. Laryngoscope Investig Otolaryngol. 2018; 3:94–99.
Kreisl W.C., Jin P., Lee S. et al. Odor identification ability predicts PET amyloid status and memory decline in older adults. J Alzheimers Dis. 2018; 62:1759–1766.
Churnin I., Qazi J., Fermin C.R. et al. Association between olfactory and gustatory dysfunction and cognition in older adults. Am J Rhinol Allergy. 2019;33:170–177.
Spotten L.E., Corish C.A., Lorton C.M. et al. Subjective and objective taste and smell changes in cancer. AnnOncol. 2017; 28:969–984.
Qiang Q., Wu X., Yang T. et al. Acomparisonbetweensystemicandintratympanicsteroidtherapiesas initial therapy for idiopathic sudden sensorineural hearing loss: a meta-analysis. Acta Otolaryngol. 2017; 137:598–605.
Han X., Yin X., Du X. et al. Combined intratympanic and systemic use of steroids as a first-line treatment for sudden sensorineural hearing loss: a meta-analysis of randomized, controlled trials. Otol Neurotol. 2017; 38:487–495.
Tikka C., Verbeek J.H., Kateman E. et al. Interventions to prevent occupational noise-induced hearing loss. Cochrane Database Syst Rev. 2017; 7:CD006396.
Kil J., Lobarinas E., Spankovich C. et al. Safety and efficacy of ebselen for the prevention of noiseinduced hearing loss: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2017; 390:969–979.
Zenner H.P., Delb W., Kroner-Herwig B. et al. A multidisciplinary systematic review of the treatment for chronic idiopathic tinnitus. Eur Arch Otorhinolaryngol. 2017; 274:2079–2091.
Beukes E.W., Andersson G., Allen P.M. et al. Effectiveness of guided internet-based cognitive behavioral therapy vs face-to-face clinical care for treatment of tinnitus: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2018; 144:1126–1133.
Zhang X., Qian X., Lu L. et al. Effects of Semont maneuver on benign paroxysmal positional vertigo: a meta-analysis. Acta Otolaryngol. 2017; 137:63–70.
Patel M., Agarwal K., Arshad Q. et al. Intratympanic methylprednisolone versus gentamicin in patients with unilateral M?ni?re’s disease: a randomised, double-blind, comparative effectiveness trial. Lancet. 2016; 388:2753–2762.
Saliba I., Gabra N., Alzahrani M. et al. Endolymphatic duct blockage: a randomized controlled trial of a novel surgical technique for M?ni?re’s disease treatment. Otolaryngol Head Neck Surg. 2015; 152:122–129.
Lin H.W., Mahboubi H., Bhattacharyya N. Self-reported hearing difficulty and risk of accidental injury in US adults, 2007 to 2015. JAMA Otolaryngol Head Neck Surg. 2018; 144:413–417.
Usami S.I., Kitoh R., Moteki H. et al. Etiology of single-sided deafness and asymmetrical hearing loss. Acta Otolaryngol. 2017; 137(suppl 565):s2–s7.
Carroll Y.I., Eichwald J., Scinicariello F. et al. Vital signs: noise-induced hearing loss among adults — United States 2011-2012. MMWR Morb Mortal Wkly Rep. 2017; 66:139–144.
Cunningham L.L., Tucci D.L. Hearing loss in adults. N Engl J Med. 2017; 377:2465–2473.
Sladen D.P., Peterson A., Schmitt M. et al. Health-related quality of life outcomes following adult cochlear implantation: a prospective cohort study. Cochlear Implants Int. 2017; 18:130–135.
Bauer C.A. Tinnitus. N Engl J Med. 2018; 378:1224–1231.
Phillips J.S., McFerran D.J., Hall D.A. et al. The natural history of subjective tinnitus in adults: a systematic review and meta-analysis of no-intervention periods in controlled trials. Laryngoscope. 2018; 128:217–227.
Brandt T., Dieterich M. The dizzy patient: don’t forget disorders of the central vestibular system. Nat Rev Neurol. 2017; 13:352–362.
Nuti D., Masini M., Mandala M. Benign paroxysmal positional vertigo and its variants. Handb Clin Neurol. 2016; 137:241–256.
Omron R. Peripheral vertigo. Emerg Med Clin North Am. 2019; 37:11–28.
Fife T.D. Dizziness in the outpatient care setting. Continuum (Minneap Minn). 2017; 23:359–395.
Whitman G.T. Examination of the patient with dizziness or imbalance. Med Clin North Am. 2019; 103:191–201.
Atzema C.L., Grewal K., Lu H. et al. Outcomes among patients discharged from the emergency department with a diagnosis of peripheral vertigo. Ann Neurol. 2016; 79:32–41.
Spinks A., Glasziou P.P., Del Mar C.B. Antibiotics for sore throat. Cochrane Database Syst Rev. 2013; 11:CD000023.
Spurling G.K., Del Mar C.B., Dooley L. et al. Delayed antibiotic prescriptions for respiratory infections. Cochrane Database Syst Rev. 2017; 9:CD004417.
van Driel M.L., De Sutter A.I., Habraken H. et al. Different antibiotic treatments for group A streptococcal pharyngitis. Cochrane Database Syst Rev. 2016; 9:CD004406.
Sadeghirad B., Siemieniuk R.A.C., Brignardello-Petersen R. et al. Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomized trials. BMJ. 2017; 358:1–10.
Morad A., Sathe N.A., Francis D.O. et al. Tonsillectomy versus watchful waiting for recurrent throat infection: a systematic review. Pediatrics. 2017; 139:1–11.
Wiksten J.E., Pitkaranta A., Blomgren K. Metronidazole in conjunction with penicillin neither prevents recurrence nor enhances recovery from peritonsillar abscess when compared with penicillin alone: a prospective, double-blind, randomized, placebo-controlled trial. J Antimicrob Chemother. 2016; 71:1681–1687.
Hayward G.N., Hay A.D., Moore M.V. et al. Effect of oral dexamethasone without immediate antibiotics vs placebo on acute sore throat in adults: a randomized clinical trial. JAMA. 2017; 317:1535–1543.
Burton M.J., Glasziou P.P., Chong L.Y. et al. Tonsillectomy or adenotonsillectomy versus non-surgical treatment for chronic/recurrent acute tonsillitis. Cochrane Database Syst Rev. 2014; 11:CD001802.
Klein M.R. Infections of the oropharynx. Emerg Med Clin North Am. 2019; 37:69–80.
Harris A.M., Hicks L.A., Qaseem A. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2016; 164:425–434.
Cohen J.F., Bertille N., Cohen R. et al. Rapid antigen detection test for group A streptococcus in children with pharyngitis. Cochrane Database Syst Rev. 2016; 7:CD010502.
Centor R.M., Atkinson T.P., Ratliff A.E. et al. The clinical presentation of Fusobacterium-positive and streptococcal-positive pharyngitis in a university health clinic: a cross-sectional study. Ann Intern Med. 2015; 162:241–247.
Li R.M., Kiemeney M. Infections of the neck. Emerg Med Clin North Am. 2019; 37:95–107.
Battaglia A., Burchette R., Hussman J. et al. Comparison of medical therapy alone to medical therapy with surgical treatment of peritonsillar abscess. Otolaryngol Head Neck Surg. 2018; 158:280–286.
Lennon P., Crotty M., Fenton J.E. Infectious mononucleosis. BMJ. 2015; 350:1–7.
Lamoth F., Lockhart S.R., Berkow E.L. et al. Changes in the epidemiological landscape of invasive candidiasis. J Antimicrob Chemother. 2018; 73:i4–i13.
Windfuhr J.P., Toepfner N., Steffen G. et al. Clinical practice guideline: tonsillitis II. Surgical management. Eur Arch Otorhinolaryngol. 2016; 273:989–1009.
Shapira Galitz Y., Shoffel-Havakuk H., Cohen O. et al. Adult acute supraglottitis: analysis of 358 patients for predictors of airway intervention. Laryngoscope. 2017; 127:2106–2112.
Chroboczek T., Cour M., Hernu R. et al. Long-term outcome of critically ill adult patients with acute epiglottitis. PLoS ONE. 2015; 10:1–8.
Kourelis T.V., Kyle R.A., Dingli D. et al. Presentation and outcomes of localized immunoglobulin light chain amyloidosis: the Mayo Clinic experience. Mayo Clin Proc. 2017; 92:908–917.
Rasmussen E.R., Schnack D.T., Ravn A.T. A prospective cohort study of 122 adult patients presenting to an otolaryngologist’s office with globus pharyngeus. Clin Otolaryngol. 2018; 43:854–860.
Stachler R.J., Francis D.O., Schwartz S.R. et al. Clinical practice guideline: hoarseness (dysphonia) (update) executive summary. Otolaryngol Head Neck Surg. 2018; 158:409–426.
Soni S., Chouksey S. A study of clinicopathological profile of patients of hoarseness of voice presenting to tertiary care hospital. Indian J Otolaryngol Head Neck Surg. 2017; 69:244–247.
Труды отечественных авторов при подготовке статей по терапии для пользователей сайта - не использовались, так как их вы всегда можете найти в библиотеках.
